Nifty pharma completed retest of downward channel breakout.
Fundamentally, Indian pharma sector should benefit from commodity breakdown, with lower raw material costs/ lower logistics cost/ power cost. It can play out as a defensive sector incase of a global meltdown.
| Subscribe To Our Free Newsletter |
